Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.

The action of insulin in the central nervous system produces sympathetic nervous system activation (also called sympathoactivation), although the neuronal intracellular mechanisms that mediate this are unclear. We hypothesized that PI3K and MAPK, the major pathways involved in insulin receptor signaling, mediate sympathetic nerve responses to insulin. Intracerebroventricular administration of insulin in rat increased multifiber sympathetic nerve activity to the hindlimb, brown adipose tissue (BAT), adrenal gland, and kidney. Ex vivo biochemical studies of mediobasal hypothalamic tissue revealed that insulin stimulated the association of insulin receptor substrate-1 with the p85alpha subunit of PI3K and also tyrosine phosphorylation of p42 and p44 subunits of MAPK in the hypothalamus. In order to determine whether PI3K and/or MAPK were involved in insulin-mediated sympathoactivation, we tested the effect of specific inhibitors of PI3K (LY294002 and wortmannin) and MAPK (PD98059 and U0126) on regional sympathetic responses to insulin. Interestingly, regional sympathoactivation to insulin was differentially affected by blockade of PI3K and MAPK. Inhibition of PI3K specifically blocked insulin-induced sympathoactivation to the hindlimb, while inhibition of MAPK specifically blocked insulin-induced sympathoactivation to BAT. Sympathoactivation to corticotrophin-releasing factor, however, was not affected by inhibition of PI3K and MAPK. These data demonstrate that PI3K and MAPK are specific and regionally selective mediators of the action of insulin on the sympathetic nervous system.

[1]  J. Carvalheira,et al.  Selective impairment of insulin signalling in the hypothalamus of obese Zucker rats , 2003, Diabetologia.

[2]  A. Mark,et al.  Role of Melanocortin-4 Receptors in Mediating Renal Sympathoactivation to Leptin and Insulin , 2003, The Journal of Neuroscience.

[3]  R. Seeley,et al.  Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. , 2003, Diabetes.

[4]  L. Rossetti,et al.  Hypothalamic insulin signaling is required for inhibition of glucose production , 2002, Nature Medicine.

[5]  E. Air,et al.  The Catabolic Action of Insulin in the Brain Is Mediated by Melanocortins , 2002, The Journal of Neuroscience.

[6]  Zhaohui Feng,et al.  Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats , 2002, Nature Neuroscience.

[7]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[8]  Jennifer L. Mitchell,et al.  Role of Corticotrophin-Releasing Factor in Effects of Leptin on Sympathetic Nerve Activity and Arterial Pressure , 2001, Hypertension.

[9]  D. Alkon,et al.  Role of insulin and insulin receptor in learning and memory , 2001, Molecular and Cellular Endocrinology.

[10]  A. Saltiel,et al.  Spatial compartmentalization of signal transduction in insulin action , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[11]  L. Landsberg.  Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why) , 2001, Journal of hypertension.

[12]  V. Routh,et al.  Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats , 2000, Nature Neuroscience.

[13]  K. Siddle,et al.  Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. , 1998, The Biochemical journal.

[14]  F. Hobbs,et al.  Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.

[15]  C. Sartori,et al.  Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. , 1997, Circulation.

[16]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[17]  P. Nicod,et al.  Insulin-Induced Sympathetic Activation and Vasodilation in Skeletal Muscle: Effects of Insulin Resistance in Lean Subjects , 1995, Diabetes.

[18]  A. Mark,et al.  Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. , 1994, The American journal of physiology.

[19]  A. Mark,et al.  Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin. , 1994, Hypertension.

[20]  T. Buchanan,et al.  Chronic insulin administration elevates blood pressure in rats. , 1994, Hypertension.

[21]  J. Porter.  Effect of intrahypothalamic insulin on sympathetic nervous function in rats drinking a high-sucrose solution. , 1994, American Journal of Physiology.

[22]  A. Mark,et al.  Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. , 1993, The American journal of physiology.

[23]  K. Kanmatsuse,et al.  Blood pressure response to hyperinsulinemia in salt-sensitive and salt-resistant rats. , 1992, Hypertension.

[24]  P. Hjemdahl,et al.  The sympathetic response to euglycaemic hyperinsulinaemia , 1992, Diabetologia.

[25]  B. Trimarco,et al.  Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. , 1992, The Journal of clinical investigation.

[26]  S. Woods,et al.  Inhibition of hypothalamic neuropeptide Y gene expression by insulin. , 1992, Endocrinology.

[27]  D. Atrens,et al.  Insulin and the paraventricular hypothalamus: modulation of energy balance , 1991, Brain Research.

[28]  E A Anderson,et al.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. , 1991, The Journal of clinical investigation.

[29]  A. Géloën,et al.  Regulation of the level of uncoupling protein in brown adipose tissue by insulin requires the mediation of the sympathetic nervous system , 1990, FEBS letters.

[30]  C. Tipton,et al.  Influences of exogenous insulin on arterial blood pressure measurements of the rat. , 1989, Journal of applied physiology.

[31]  V. Katch,et al.  Insulin and Renal Sodium Retention in Obese Adolescents , 1989, Hypertension.

[32]  G. Werther,et al.  Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. , 1987, Endocrinology.

[33]  H. Gavras,et al.  Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. , 1982, The Journal of clinical investigation.

[34]  J W Rowe,et al.  Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal Man , 1981, Diabetes.

[35]  M. Brownstein,et al.  Insulin receptors are widely distributed in the central nervous system of the rat , 1978, Nature.

[36]  A. J. Szabo,et al.  Studies on the Nature and Mode of Action of the Insulin-sensitive Glucoregulator Receptor in the Central Nervous System , 1975, Diabetes.

[37]  S. Woods,et al.  Insulin and leptin as adiposity signals. , 2004, Recent progress in hormone research.

[38]  E. Raff,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[39]  P. Cohen,et al.  Specificity and mechanism of action of some commonly used protein kinase inhibitors. , 2000, The Biochemical journal.

[40]  L. Vollenweider.  Insulin-induced sympathetic activation and vasodilatation in skeletal muscle. , 1996 .

[41]  A. J. Szabo,et al.  Insulin injected into CNS structures or into the carotid artery: effect on carbohydrate homeostasis of the intact animal. , 1983, Advances in metabolic disorders.